Delivery Order SPE2DB22D1017-SPE2DB25FF3JN

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The $4,999.59 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,436.36 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. The contract has an ultimate completion date of March 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,383.29 firm fixed-price delivery order is for JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract has an ultimate completion date of March 7, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D2005|SPE2DB25FJHR2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,469.73 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medical product used for diabetes management. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,906.24 firm fixed-price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a medication used to treat diabetes. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,654.93 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,834.57 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. The award has an ultimate completion date of February 21, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,475.83 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,214.20 firm fixed price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of February 4, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, SPE2DB20D1004|SPE2DB24FG3C5, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,611.60 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF3JN
    Delivery Order

This federal contract award, with ID SPE2DB22D1017 and SPE2DB25FF3JN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,460.95 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used for diabetes management.

The award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, is responsible for delivering the requested pharmaceutical product to the government. The company's extensive federal contract history and supply chain capabilities make it a key vendor for the DLA and other government agencies in providing essential medical commodities to military and veterans' healthcare systems.

Generated 5/21/25, 9:46 AM